Critical point here
"The clinical trial will compare the clinical performance of conventional autografting to that of widely meshed autografting with the RECELL System on acute non-burn full-thickness skin defects, with the goal of demonstrating that less donor skin is needed without compromising healing outcomes.
Very specifically Recell is meant to be used only in conjuction with widely meshed skin grafts to enable greater coverage. It seems many investors are unaware of this requirement.
- Forums
- ASX - By Stock
- RE: BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction
Critical point here "The clinical trial will compare the...
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.80 |
Change
-0.030(1.06%) |
Mkt cap ! $197.1M |
Open | High | Low | Value | Volume |
$2.83 | $2.89 | $2.80 | $299.8K | 105.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3700 | $2.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.83 | 10724 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 2.790 |
1 | 2400 | 2.780 |
1 | 500 | 2.770 |
1 | 2000 | 2.760 |
1 | 4000 | 2.750 |
Price($) | Vol. | No. |
---|---|---|
2.830 | 10724 | 2 |
2.870 | 14722 | 3 |
2.880 | 14249 | 3 |
2.890 | 9500 | 1 |
2.900 | 5050 | 4 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online